Citius Pharmaceuticals gets high-upside price target based on Mino-Lok Phase 3 trial
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Dawson James sees Cytosorbents Cytosorb as approvable, but raises risk (NASDAQ:CTSO)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.